To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05515406
Title A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ono Pharmaceutical Co. Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Jonsson Comprehensive Cancer Center Santa Monica California 90404 United States Details
AMR Kansas City Kansas City Missouri 64114 United States Details
Leo Jenkins Cancer Center/ECU School of Medicine Greenville North Carolina 27858 United States Details
University of Cincinnati Cincinnati Ohio 45267 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Baylor Scott & White Research Institute Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Northwest Medical Specialities Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field